Primary |
Osteoarthritis |
18.8% |
Back Pain |
12.5% |
Hypertension |
12.5% |
Pain |
12.5% |
Arthralgia |
6.3% |
Atrial Fibrillation |
6.3% |
Colon Cancer |
6.3% |
Cough |
6.3% |
Groin Pain |
6.3% |
Schizophrenia, Paranoid Type |
6.3% |
Sciatica |
6.3% |
|
Syncope |
15.4% |
Angioedema |
7.7% |
Asthma |
7.7% |
Headache |
7.7% |
Hyperkalaemia |
7.7% |
Melaena |
7.7% |
Oedema Peripheral |
7.7% |
Radiculitis |
7.7% |
Throat Tightness |
7.7% |
Thrombosis |
7.7% |
Toxic Epidermal Necrolysis |
7.7% |
Upper Gastrointestinal Haemorrhage |
7.7% |
|
Secondary |
Arthralgia |
20.9% |
Hypertension |
15.0% |
Product Used For Unknown Indication |
14.4% |
Drug Use For Unknown Indication |
8.5% |
Chest Pain |
6.5% |
Hepatitis C |
6.5% |
Neuralgia |
6.5% |
Diabetes Mellitus |
3.9% |
Atrial Fibrillation |
2.6% |
Supplementation Therapy |
2.6% |
Type 2 Diabetes Mellitus |
2.6% |
Arrhythmia |
1.3% |
Congenital Cystic Kidney Disease |
1.3% |
Coronary Artery Disease |
1.3% |
Gout |
1.3% |
Hypercholesterolaemia |
1.3% |
Prophylaxis |
1.3% |
Diarrhoea |
0.7% |
Hyperlipidaemia |
0.7% |
Immunosuppression |
0.7% |
|
Melaena |
19.0% |
Renal Failure Acute |
14.3% |
Overdose |
9.5% |
Pulse Absent |
9.5% |
Upper Respiratory Tract Infection |
9.5% |
Abdominal Pain Upper |
4.8% |
Gastrointestinal Haemorrhage |
4.8% |
Tachycardia |
4.8% |
Thrombocytopenia |
4.8% |
Toxic Epidermal Necrolysis |
4.8% |
Toxicity To Various Agents |
4.8% |
Unresponsive To Stimuli |
4.8% |
Vomiting |
4.8% |
|
Concomitant |
Prophylaxis |
15.5% |
Hypertension |
12.9% |
Drug Use For Unknown Indication |
11.8% |
Non-small Cell Lung Cancer |
10.5% |
Product Used For Unknown Indication |
6.1% |
Oropharyngeal Cancer Stage Unspecified |
4.8% |
Hyperuricaemia |
4.4% |
Radiation Dysphagia |
4.2% |
Squamous Cell Carcinoma |
4.1% |
Hypercreatininaemia |
3.0% |
Arthralgia |
2.8% |
Renal Cell Carcinoma Stage Unspecified |
2.8% |
Bone Pain |
2.6% |
Renal Cell Carcinoma |
2.6% |
Rheumatoid Arthritis |
2.4% |
Cancer Pain |
2.0% |
Diarrhoea |
2.0% |
Conjunctivitis |
1.8% |
Metastatic Renal Cell Carcinoma |
1.8% |
Palmar-plantar Erythrodysaesthesia Syndrome |
1.8% |
|
Pyrexia |
13.6% |
Renal Failure |
13.6% |
Sudden Death |
8.6% |
Vomiting |
7.4% |
Sinusitis |
6.2% |
Empyema |
4.9% |
Pelvic Abscess |
4.9% |
Shock |
4.9% |
Tachycardia |
4.9% |
Vascular Insufficiency |
4.9% |
Abdominal Pain |
3.7% |
Blood Thyroid Stimulating Hormone Increased |
2.5% |
Fatigue |
2.5% |
Gastrointestinal Disorder |
2.5% |
Haemorrhage |
2.5% |
Hepatic Enzyme Increased |
2.5% |
Infusion Related Reaction |
2.5% |
Metastases To Meninges |
2.5% |
Neutrophil Count Decreased |
2.5% |
Paraparesis |
2.5% |
|